Position in NVAX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$235
New position
Shares Held
25
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 26 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Darwin Wealth Management, LLC holds $3,593,117 across 9 Biotechnology names. NVAX ranks #4 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DYN |
Dyne Therapeutics, Inc.
|
155,270 | $3,448,546 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
500 | $93,640 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
925 | $50,449 | |
| 4 | NVAX |
Novavax Inc
This page
|
25 | $235 | |
| 5 | ABEO |
Abeona Therapeutics Inc.
|
26 | $160 | |
| 6 | ENLV |
Enlivex Ltd.
|
150 | $82 | |
| 7 | XBIO |
Xenetic Biosciences, Inc.
|
2 | $5 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
0 | $0 |
All Filings in NVAX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235 | 25 | Shares | Sole | 2026-07-21 | |
| No filing history on record for this holder in this stock. | ||||||